Seeking Alpha

Baxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for...

Baxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for hemophilia A. The firm says the phase I trial is the first step in assessing if the drug can be infused less frequently.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs